Rockefeller Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Rockefeller Capital Management's HALO Position: Q2 2026 in Review
Rockefeller Capital Management increased its Halozyme (HALO) stake by 6.4% in Q2 2026, buying an estimated $33.3K and bringing the position to 8,111 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #1962.
Rockefeller Capital Management first reported a position in HALO in Q4 2019 and has held it in 24 quarters since. The position peaked at $3.78M in Q3 2024. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Rockefeller Capital Management held 8,111 shares of Halozyme worth $635K as of Q2 2026.
- Rockefeller Capital Management bought 489 Halozyme shares in Q2 2026, an estimated $33.3K.
- Halozyme made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1962 holding.
- Rockefeller Capital Management first reported a position in Halozyme in Q4 2019 and has held it in 24 quarters since.
- Rockefeller Capital Management's Halozyme position peaked at $3.78M in Q3 2024.
- 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.